<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03054922</url>
  </required_header>
  <id_info>
    <org_study_id>IRB16-01093</org_study_id>
    <nct_id>NCT03054922</nct_id>
  </id_info>
  <brief_title>Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables</brief_title>
  <official_title>Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      During major surgical procedures, intravascular volume is maintained with the administration
      of isotonic fluids such as Lactated Ringers (LR), Normal Saline (NS) or Normosol-R. All three
      of these fluids are in common clinical use for this purpose. As large volumes of NS may
      result in a dilutional acidosis and an increasing base deficit, it may cloud clinical
      decision making when resuscitative efforts are guided by acid-base status on routine arterial
      blood gas analysis. This is a prospective, randomized study to evaluate changes in acid-base
      and electrolyte (sodium, potassium, calcium) status with the use of various isotonic fluids
      for intraoperative resuscitation.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">February 23, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Base deficit</measure>
    <time_frame>End of surgery (typically 4-6 hrs after baseline or start of surgery)</time_frame>
    <description>Obtained from blood gas to measure metabolic acidosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sodium</measure>
    <time_frame>End of surgery (typically 4-6 hrs after baseline or start of surgery)</time_frame>
    <description>Level of sodium electrolyte in blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potassium</measure>
    <time_frame>End of surgery (typically 4-6 hrs after baseline or start of surgery)</time_frame>
    <description>Level of potassium electrolyte in blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ionized calcium</measure>
    <time_frame>End of surgery (typically 4-6 hrs after baseline or start of surgery)</time_frame>
    <description>Level of calcium electrolyte in blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluid requirement</measure>
    <time_frame>End of surgery (typically 4-6 hrs after baseline or start of surgery)</time_frame>
    <description>Amount of fluid required for resuscitation during surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine output</measure>
    <time_frame>End of surgery (typically 4-6 hrs after baseline or start of surgery)</time_frame>
    <description>Amount of urine produced during surgery</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.9% Sodium Chloride</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactated Ringers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each 100 mL of Lactated Ringer's Injection USP contains:
Sodium Chloride USP 0.6 g; Sodium Lactate USP 0.31 g; Potassium Chloride USP 0.03 g; Calcium Chloride Dihydrate USP 0.02 g; Water for Injection USP qs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normosol-R</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each 100 mL of Normosol-R contains sodium chloride, 526 mg; sodium acetate, 222 mg; sodium gluconate, 502 mg; potassium chloride, 37 mg; magnesium chloride hexahydrate, 30 mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>IV infusion of 0.9% NaCl throughout surgery.</description>
    <arm_group_label>Normal Saline</arm_group_label>
    <other_name>0.9% NaCl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactated Ringer</intervention_name>
    <description>IV infusion of lactated ringer throughout surgery.</description>
    <arm_group_label>Lactated Ringers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normosol-R Inj</intervention_name>
    <description>IV infusion of Normosol throughout surgery.</description>
    <arm_group_label>Normosol-R</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major surgical procedure requiring arterial access

        Exclusion Criteria:

          -  Comorbid disease process that contraindicates the use of any 1 of the 3 crystalloid
             solutions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2017</study_first_submitted>
  <study_first_submitted_qc>February 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 16, 2017</study_first_posted>
  <last_update_submitted>February 23, 2018</last_update_submitted>
  <last_update_submitted_qc>February 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>David P. Martin</investigator_full_name>
    <investigator_title>Director, Acute Pain Services</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Plasma-lyte 148</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

